METATRON
LIVE

Serial Number

90790908

Owner

INSTITUTE OF PRACTICAL PSYCHOPHYSICS

Attorney

Charlene Azema

Filing Date

Jun 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

METATRON Trademark

Serial Number: 90790908 • Registration: 7819363

METATRON is a trademark filed by INSTITUTE OF PRACTICAL PSYCHOPHYSICS on June 23, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

INSTITUTE OF PRACTICAL PSYCHOPHYSICS

Proizvodstvennaya 2
Omsk Omskaya Oblast' 644031 , RU

Entity Type: 16

Trademark Details

Filing Date

June 23, 2021

Registration Date

June 3, 2025

Published for Opposition

March 12, 2024

Goods & Services

Medical device, namely, diagnostic biofeedback apparatus in the nature of medical biofeedback sensors; Medical diagnostic apparatus for the detection of disease, namely, medical diagnostic apparatus for detecting pathologies at early stages, blood cell abnormalities, tissue abnormalities, organ function abnormalities, and viral, helminth, bacterial, fungal and other pathogenic infections; Medical diagnostic apparatus for the detection of blood cell abnormalities, tissue abnormalities, and organ function abnormalities; medical imaging apparatus; medical imaging apparatus for digital three-dimensional organ and tissue modeling; medical diagnostic instrument for analysis of body fluids and cell frequency; medical products, namely, biofeedback sensors; medical diagnostic apparatus for testing of tissue and cell destruction; medical diagnostic apparatus for impulse and resonance detection; medical diagnostic apparatus for detecting viral, helminth, bacterial, fungal and other pathogenic infections; medical diagnostic apparatus for the detection of pathologies at early stages, namely, infectious diseases and cancers; medical apparatus for prevention of development of disease, namely, medical apparatus for the early detection of infections, cell abnormalities and cancers; medical diagnostic instrument using bioresonance, namely, imaging apparatus for medical purposes; medical apparatus for treatment of muscular structural imbalance; medical apparatus for diagnostic and medical purposes, namely, electromagnetic resonance imaging; medical imaging apparatus with embedded operating system software; medical device, namely, biofeedback sensors that transmit waves through the body to test body function, interpret body and organ health, assess overall physiological functional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, neurofeedback device that transmits waves through the brain to test body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, bioresonance sensors that transmit waves through the body to test body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect abnormalities, for medical, diagnostic and therapeutic purposes; medical device, namely, diagnostic biofeedback hardware in the nature of sensors for evaluating the psycho-physiological condition of a patient on the whole, namely, blood pressure, lung capacity, cardiac output, brain activity, and bodily reflexes, and diagnosing of many illnesses and progressing states; medical device, namely, diagnostic hardware for screening diagnostics of the functional status of human organs and systems; medical device, namely, diagnostic hardware for determining the probabilistic localization of functional change locuses and for locating the epicenter of the disease process for medical diagnostic and treatment purposes; medical device, namely, diagnostic hardware for assessing dynamics of dysfunctional changes in a human body and for assessing the bettering or worsening condition of patient; medical device, namely, diagnostic hardware for assessing the basic parameters of a biosystem homeostasis for medical diagnostic and treatment purposes; Medical device for the performance of informational therapy which represents the effect on an organism of a combination of various modulated oscillations emitted by the device, namely, audio oscillators for detecting toxins and pathogens in the body for medical diagnostic purposes; Medical device for the performance of Lithotherapy which transmits the spectral characteristics of the selected mineral; Medical device for the performance of Phytotherapy which transmits the spectral characteristics of the selected herb; Medical therapeutic device for the performance of psycho-wave correction which is used for psychotherapeutic disorders correction by means of flower essences' spectrum characteristics; Medical therapeutic device for the transmission of a wave function that depresses the wave function of pathological infectious diseases, resulting in a decline of the level of the pathological organism's adaptive responses; embedded software, sold as a component of medical devices, namely, biofeedback sensors and medical apparatus for monitoring vital signs of patients that test and analyze body function, interpret body and organ health, assess overall physiological functional health and psychoemotional health, and detect physiological abnormalities

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 13, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 13, 2025 CNPR
EXAMINER'S AMENDMENT ENTERED
May 13, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 13, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 13, 2025 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
May 13, 2025 SNEA
STATEMENT OF USE PROCESSING COMPLETE
May 5, 2025 SUPC
USE AMENDMENT FILED
Nov 7, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 7, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 7, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 6, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 6, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 6, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 6, 2024 CNEA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 10, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 1, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 1, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 1, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 1, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 1, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
NEW APPLICATION ENTERED
Jun 26, 2021 NWAP